matrix metalloproteinase inhibitor

This page covers all matrix metalloproteinase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting matrix metalloproteinases, Matrix metalloproteinases (MMPs).

Targets

matrix metalloproteinases · Matrix metalloproteinases (MMPs)

Marketed (1)

• ActiveMatrix · Baylor College of Medicine · Oncology
  ActiveMatrix is a matrix metalloproteinase inhibitor.

Phase 3 pipeline (1)

• local tetracycline · The Forsyth Institute · Dentistry / Periodontics
  Local tetracycline delivery inhibits matrix metalloproteinases and reduces inflammation in periodontal tissues.

Patent intelligence

• matrix metalloproteinase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates